XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
Preferred Stock Series A [Member]
Preferred Stock Series B [Member]
Preferred Stock Series C [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 0 $ 0 $ 9,400 $ 60 $ 89,863,947 $ (66,404,190) $ (30,755) $ 2,682,339 $ 26,120,801
Beginning balance, shares at Dec. 31, 2021 0 0 9,400,309 59,534          
Net loss (16,332,636) (434,102) (16,766,738)
Change in foreign currency translation (135,374) (135,374)
Conversion of Series C preferred stock into common stock $ (118) 118
Conversion of Series C preferred stock into common stock, shares     (118,500) 103          
Dividends declared for Series C preferred stock (735,586) (735,586)
Issuance of common stock as payment for Series C preferred stock dividends payable $ 1 833,738 833,739
Issuance of common stock as payment for Series C preferred stock dividends payable, shares       1,352          
Issuance of common stock in connection with sales made under public offerings $ 71 4,085,259 4,085,330
Issuance of common stock in connection with sales made under public offerings, shares       70,784          
Issuance of common stock in connection with sales made under private offerings $ 3 274,997 275,000
Issuance of common stock in connection with sales made under private offerings, shares       2,575          
Issuance of common stock in connection with the exercise of common stock purchase warrants $ 14 265 279
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares       13,953          
Issuance of common stock in exchange for consulting, professional and other services 116,736 116,736
Issuance of common stock in exchange for consulting, professional and other services, shares       298          
Conversion of note principal and accrued interest into common stock $ 15 5,874,985 5,875,000
Conversion of note principal and accrued interest into common stock, shares       14,997          
Recognition of beneficial conversion features related to notes payable 363,329 363,329
Stock based compensation expense related to stock options 315,332 315,332
Ending balance, value at Dec. 31, 2022 $ 0 $ 0 $ 9,282 $ 164 101,728,706 (83,472,412) (166,129) 2,248,237 20,347,848
Ending balance, shares at Dec. 31, 2022 0 0 9,281,809 163,596          
Net loss (12,527,429) (1,351,728) (13,879,157)
Change in foreign currency translation 6,526 6,526
Dividends declared for Series C preferred stock (742,546) (742,546)
Repurchase and retirement of Series C preferred stock     $ (39) (1) (40)
Repurchase and retirement of Series C preferred stock, shares     (38,500)            
Issuance of common stock in connection with sales made under public offerings $ 946 2,459,692 2,460,638
Issuance of common stock in connection with sales made under public offerings, shares       946,000          
Issuance of common stock in connection with sales made under private offerings $ 5 2,487,854 2,487,859
Issuance of common stock in connection with sales made under private offerings, shares       5,000          
Issuance of common stock in connection with the exercise of common stock purchase warrants $ 854 11,509 12,363
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares       854,641          
Issuance of common stock in exchange for consulting, professional and other services $ 1 31,967 31,968
Issuance of common stock in exchange for consulting, professional and other services, shares       1,167          
Issuance of common stock purchase warrants as consideration for waiver of a financing covenant 350,038 350,038
Fair value of common stock purchase warrants issued with notes payable 1,102,852 1,102,852
Stock based compensation expense related to stock options 139,067 139,067
Ending balance, value at Dec. 31, 2023 $ 0 $ 0 $ 9,243 $ 1,970 $ 108,311,684 $ (96,742,387) $ (159,603) $ 896,509 $ 12,317,416
Ending balance, shares at Dec. 31, 2023 0 0 9,243,309 1,970,404